SCHEDULE: Vanguard Group Reports Zero Albemarle Stake After Realignment

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Albemarle Corp following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 14 to its Schedule 13G for Albemarle Corp.
• The filing reports 0 shares beneficially owned, representing 0% of Albemarle Corp's Common Stock.
• This change is due to an internal realignment within The Vanguard Group, Inc. on January 12, 2026.
• Certain subsidiaries or business divisions will now report beneficial ownership separately, disaggregated from The Vanguard Group, Inc., in reliance on SEC Release No. 34-39538.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over these securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily a procedural update reflecting an internal organizational change at Vanguard rather than a substantive shift in investment or company performance.

Positives

• The Vanguard Group is maintaining compliance with SEC regulations by updating its beneficial ownership reporting following an internal realignment.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.
• Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors holding less than 20% of a company's stock, primarily for passive investment purposes. This specific amendment reflects an internal organizational change at Vanguard rather than a change in investment thesis regarding Albemarle.

Comparison to Industry Standards

• NA

Corporate Governance

Stakeholder Impact

• Shareholders (Albemarle): Minimal direct impact as the underlying investment strategies of Vanguard's subsidiaries remain the same; it's a reporting change.
• Shareholders (Vanguard Funds): No direct impact on fund holdings or strategies, only on the reporting mechanism.
• Regulatory Authorities (SEC): Ensures continued compliance with beneficial ownership reporting requirements under Rule 13d-1(b).

Next Steps

• Vanguard's subsidiaries or business divisions will now report their beneficial ownership separately.

Key Dates

Keywords

Albemarle Corp, Vanguard Group, Schedule 13G, beneficial ownership, institutional ownership, SEC filing, common stock, investment adviser, realignment